Terms: = Breast cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
695 results:
1. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
[TBL] [Abstract] [Full Text] [Related]
2. Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer.
Inayatullah M; Mahesh A; Turnbull AK; Dixon JM; Natrajan R; Tiwari VK
EMBO Mol Med; 2024 Apr; 16(4):823-853. PubMed ID: 38480932
[TBL] [Abstract] [Full Text] [Related]
3. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative breast cancer Metastases.
Ito K; Harada I; Martinez C; Sato K; Lee E; Port E; Byerly JH; Nayak A; Tripathi E; Zhu J; Irie HY
Cancer Res Commun; 2024 Mar; 4(3):946-957. PubMed ID: 38457262
[TBL] [Abstract] [Full Text] [Related]
4. SORBS1 inhibits epithelial to mesenchymal transition (emt) of breast cancer cells by regulating PI3K/AKT signaling and macrophage phenotypic polarization.
Feng K; Di Y; Han M; Yan W; Wang Y
Aging (Albany NY); 2024 Mar; 16(5):4789-4810. PubMed ID: 38451194
[TBL] [Abstract] [Full Text] [Related]
5. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative breast cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract] [Full Text] [Related]
6. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
7. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
8. Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.
Li SY; Hammarlund JA; Wu G; Lian JW; Howell SJ; Clarke RB; Adamson AD; Gonçalves CF; Hogenesch JB; Anafi RC; Meng QJ
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2311854121. PubMed ID: 38319971
[TBL] [Abstract] [Full Text] [Related]
9. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract] [Full Text] [Related]
10. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer.
Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A
Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470
[TBL] [Abstract] [Full Text] [Related]
12. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract] [Full Text] [Related]
13. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
14. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract] [Full Text] [Related]
15. USP30 promotes the progression of breast cancer by stabilising Snail.
Sun K; Liao S; Yao X; Yao F
Cancer Gene Ther; 2024 Mar; 31(3):472-483. PubMed ID: 38146008
[TBL] [Abstract] [Full Text] [Related]
16. PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy.
Lyu L; Li H; Lu K; Jiang S; Li H
Br J Cancer; 2024 Feb; 130(3):394-405. PubMed ID: 38110664
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial to mesenchymal transition (emt) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract] [Full Text] [Related]
18. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.
Martínez-López A; García-Casas A; Infante G; González-Fernández M; Salvador N; Lorente M; Mendiburu-Eliçabe M; Gonzalez-Moreno S; Villarejo-Campos P; Velasco G; Malliri A; Castillo-Lluva S
Mol Oncol; 2024 Mar; 18(3):620-640. PubMed ID: 38098337
[TBL] [Abstract] [Full Text] [Related]
19. GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition.
Li M; Wang X; Chen X; Hong J; Du Y; Song D
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166925. PubMed ID: 38084873
[TBL] [Abstract] [Full Text] [Related]
20. Tumor Suppressive Role of MicroRNAs in Triple Negative breast cancer.
Balkrishna A; Mittal R; Arya V
Curr Pharm Des; 2023; 29(42):3357-3367. PubMed ID: 38037837
[TBL] [Abstract] [Full Text] [Related]
[Next]
